Verition Fund Management
ASTX

Verition Fund Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Verition Fund Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-62,900
Closed -$533K – 787
2013
Q3 		$533K Buy
+62,900
New +$398K 0.08% 200

Verition Fund Management's ASTX Position: Q4 2013 in Review

Verition Fund Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 71,732 shares — an estimated $608K sold.

Verition Fund Management first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $608K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Verition Fund Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Verition Fund Management sold 71,732 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $608K.
  • Verition Fund Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Verition Fund Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $608K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Verition Fund Management's 13F filing for Q4 2013, filed 14 Feb 2014.